End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19 MXN | -0.26% | -0.52% | 0.00% |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 603M | C+ | ||
+1.22% | 78.18B | B | ||
+0.59% | 47.18B | A- | ||
+0.96% | 32.47B | C | ||
+8.75% | 18.01B | B | ||
-9.28% | 11.74B | B | ||
+8.55% | 11.47B | A- | ||
-2.33% | 10.43B | - | ||
+5.97% | 9.98B | A- | ||
+3.48% | 9.12B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CYDSASA A Stock
- Ratings Cydsa, S.A.B. de C.V.